Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115591) titled 'Diagnostic Value of Lipid Indices Detected by J-difference Edited Magnetic Resonance Spectroscopy in Prostate Cancer' on Dec. 29, 2025.
Study Type: Diagnostic test
Study Design:
Cross-sectional
Primary Sponsor: The First Affiliated Hospital, Zhejiang University School of Medicine
Condition:
Prostate Cancer
Intervention:
Gold Standard:Needle biopsy or surgical pathology
Recruitment Status: Not Recruiting
Phase: Diagnostic New Technique Clincal Study
Date of First Enrollment: 2026-01-04
Target Sample Size: Target condition:54;Difficult condition:54
Countries of Recruitment:
China
To know more, visi...